<DOC>
	<DOCNO>NCT01042444</DOCNO>
	<brief_summary>This multi center , prospective study design demonstrate safety performance GARDEX Embolic Protection System use adjunctive device saphenous vein graft ( SVG ) intervention .</brief_summary>
	<brief_title>Use GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions Saphenous Vein Graft</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Anticipated patient life expectancy least 1 year enrollment . Patient ( legal guardian ) provide sign informed consent . Patient willing comply protocol requirement . Candidate PCI , stenting CABG . Total CK verify within hospital normal limit time enrollment . Myocardial ischemia evidence one following : Diagnosis time enrollment stable unstable angina pectoris Reversible 12 lead ECG change consist ischemia Positive function study ( e.g . stress test ) Recent myocardial infarction ( &gt; 24 hour prior enrollment total CK verify within hospital normal limit time enrollment ) . Lesions amendable PCI . Lesion ( ) locate within SVG ≥50 % &lt; 100 % stenosis ( angiographic visual assessment ) . Only single SVG graft treat . Vessel thrombolysis myocardial infarction ( TIMI ) grade 1 high flow passage guidewire . Reference vessel diameter GARDEX™ system place ≥ 3.5mm ≤6.0mm diameter angiographic visual estimation . A hypersensitivity contraindication heparin bivalirum ( Angiomax ) , aspirin , ticlopidine , clopidogrel , murine product , procedure equipment material , sensitivity contrast dye adequately pretreated diphenhydramine and/or steroid . Myocardial infarction document total CK &gt; 2 time upper limit normal within past 24 hour , currently experience acute myocardial infarction . A stroke transient ischemic attach ( TIA ) within past 2 month . A history bleed diathesis coagulopathy . Major gastrointestinal ( GI ) bleed within 3 month index procedure . Baseline creatinine ≥ 2.5 mg/dl . A planned invasive surgical procedure within 30 day . Undergone cardiac surgery within past 60 day . The lesion SVG le 2 month post implant . Left ventricular ejection fraction &lt; 20 % The lesion arterial conduit . Anatomical exclusion preclude placement GARDEX™ system per Instruction Use . More one SVG graft need treat index procedure . Chronic occlusion target lesion/severe calcification .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Heart disease</keyword>
	<keyword>Embolic Protection Device</keyword>
	<keyword>PCI</keyword>
	<keyword>SVG</keyword>
</DOC>